Abstract:Background: Brain 18F-AV-45 amyloid positron emission tomography (PET) in Taiwanese patients with familial Alzheimer's disease with the amyloid precursor protein (APP) p.D678H mutation tends to involve occipital and cerebellar cortical areas. However, tau pathology in patients with this specific Taiwan mutation remains unknown. In this study, we aimed to study the Tau PET images in these patients.Methods: Clinical features, brain magnetic resonance imaging/computed tomography (MRI/CT), and brain 18F-THK-5351 PET were recorded in five patients with the APP p.D678H mutation and correlated with brain 18F-AV-45 PET images. We also compared the tau deposition patterns among five patients with familial mild cognitive impairment (fMCI), six patients with sporadic amnestic mild cognitive impairment (sMCI), nine patients with mild to moderate dementia due to Alzheimer's disease (AD), and 12 healthy controls (HCs). All of the subjects also received brain 18F-AV-45 PET.Results: The nine patients with sAD and six patients with sMCI had a positive brain AV-45 PET scans, while the 12 HCs had negative brain AV-45 PET scans. All five patients with fMCI received a tau PET scan with the age at onset ranging from 46 to 53 years, in whom increased standard uptake value ratio (SUVR) of 18F-THK-5351 was noted in all seven brain cortical areas compared with the HCs. In addition, the SUVRs of 18F-THK-5351 were increased in the frontal, medial parietal, lateral parietal, lateral temporal, and occipital areas (P < 0.001) in the patients with sAD compared with the HCs. The patients with fMCI had a significant higher SUVR of 18F-THK-5351 in the cerebellar cortex compared to the patients with sMCI. The correlations between regional SUVR and Mini-Mental State Examination score and between regional SUVR and clinical dementia rating (sum box) scores within volumes of interest of Braak stage were statistically significant.Conclusion: Tau deposition was increased in the patients with fMCI compared to the HCs. Increased regional SUVR in the cerebellar cortical area was a characteristic finding in the patients with fMCI. As compared between amyloid and tau PET, the amyloid deposition is diffuse, but tau deposition is limited to the temporal lobe in the patients with fMCI.

An APP Mutation Family Exhibiting White Matter Hyperintensities and Cortical Calcification in East China

Probable Novel APP Met671Leu Mutation in a Chinese Han Family with Early-Onset Alzheimer's Disease

Novel APP K724M Mutation Causes Chinese Early-Onset Familial Alzheimer's Disease and Increases Amyloid-Β42 to Amyloid-Β40 Ratio.

Amyloid PET pattern with dementia and amyloid angiopathy in Taiwan familial AD with D678H APP mutation

Mutation Screening in Chinese Patients with Familial Alzheimer's Disease by Whole-Exome Sequencing.

Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer's disease

E674Q (Shanghai APP mutant), a novel amyloid precursor protein mutation, in familial late-onset Alzheimer's disease

Altered Spontaneous Brain Activity Pattern in Cognitively Normal Young Adults Carrying Mutations of APP, Presenilin-1/2 and APOE Ε4.

Early-Onset Cerebral Amyloid Angiopathy and Alzheimer Disease Related to an APP Locus Triplication

P3‐120: MOLECULAR GENETIC ANALYSIS OF APP, PSEN1, AND PSEN2 GENES IN CHINESE PATIENTS WITH ALZHEIMER'S DISEASE

Clinical and genetic characteristics in a central-southern Chinese cohort of early-onset Alzheimer's disease

Presenilin 1 and APP Gene Mutations in Early-Onset AD Families from a Southeast Region of China.

The pathogenic APP N-terminal Val225Ala mutation alters tau protein liquid-liquid phase separation and exacerbates synaptic damage

Tau PET With 18F-THK-5351 Taiwan Patients With Familial Alzheimer's Disease With the APP p.D678H Mutation

PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer's disease.

The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer’s Disease

Human Prion Disease with a G114V Mutation and Epidemiological Studies in a Chinese Family: a Case Series

Identification of a Novel Mutation in the Presenilin 1 Gene in a Chinese Alzheimer’s Disease Family

Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Shared and unique effects of ApoEε4 and pathogenic gene mutation on cognition and imaging in preclinical familial Alzheimer's disease